Number | Statement |
---|---|
8. | When treating a depressed patient who has failed to respond to two antidepressants, I do tend to add lithium first |
10. | When treating a depressed patient who has failed to respond to two antidepressants, I believe the best option is to combine esketamine (if currently available or when available in my centre) |
11. | I am satisfied with the efficacy of lithium and/or antipsychotics as augmentation therapies for patients with TRD |
13. | After obtaining a satisfactory response to treatment in a patient with TRD, long-term maintenance of therapy is essential |
14. | In my opinion most patients with TRD can be treated with esketamine nasal spray in a community outpatient setting, without difficulties |
15. | Educational support for patients helps to make the best use of the therapeutic opportunity offered by esketamine nasal spray |
16. | In my daily reality, I have adequate and sufficient resources (staff, logistics, facilities, etc.) to provide patients with TRD with the best possible care |
17. | In my opinion there are aspects of professional responsibility that the clinician must take into consideration in order to prefer, when possible, drugs with approved clinical indications for patients with TRD |